|
|
40
|
|
|
22827
|
|
|
ACETAZOLAMIDE 500MG INJ (MAT/AHI)
|
|
|
ACETAZOLAMIDE
|
|
|
ACETAZOLAMIDE
|
|
|
500MG VIAL
|
|
|
BQ
|
|
|
182.67
|
|
|
182.67
|
|
|
500MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
MAT
|
|
|
MYLAN LABORATORIES
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
402804
|
|
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|